National Medicines Symposium 2024 speakers (L to R): Steve Waller, Professor Jennifer Martin, Professor Libby Roughead, Tegan Taylor[/caption]
This CPD activity is sponsored by Reckitt. All content is the true, accurate and independent opinion of the speakers and the views expressed are entirely their own.[/caption]
Risk factors for long-term opioid misuse
Younger age, substance dependence, mental health histories and higher opioid doses are the risk factors most consistently associated with problematic opioid use
Laudanum – a panacea for all human woes?
Laudanum’s use, and abuse, has set the tone for the use and abuse of opiates from the 17th century until the present day.
From...
Pharmacists soon to provide shingles management
Herpes Zoster (HZ), or shingles, is a common viral infection, with one in three people developing the condition in their lifetime.
Changes to injectable weight loss medicines
The landscape for glucagon-like peptide-1 receptor agonists (GLP-1RAs) used for weight loss is changing in Australia as demand continues to grow.
When to use Cautionary Advisory Labels
Cautionary Advisory Labels (CALs) are applied in addition to the dispensed label at the point of dispensing. The colour and design are intended to...
Should ibuprofen be used for COVID-19 symptoms?
There is currently no peer-reviewed, published scientific evidence to support a direct link between use of ibuprofen and more severe infection with COVID-19.
